NCT05148754View on ClinicalTrials.gov

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2021

Primary Completion Date

August 15, 2021

Study Completion Date

August 16, 2021

Conditions

Covid19HIV-1-infection

Interventions

DRUG

Elsulfavirine

Elsulfavirin 200 mg tablets.

Trial Locations (1)

109263

"State Budgetary Institution Healthcare of the City of Moscow V. P. Demikhov City Clinical Hospital of the Department of Healthcare of the City of Moscow", Moscow